The utilization of everolimus-eluting coronary stents in a coronary artery diseases is effective in reducing both repeat revascularization and major adverse cardiac events within two year follow-up. To evaluate the procedural, short and long term clinical outcomes of multiple everolimus-eluting coronary stent implantation in long (\>30mm) coronary lesions.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
450
Everolimus-eluting stent implantation in patients with long coronary artery disease
Target lesion revascularization rate
Time frame: 1 year
Technical success
Time frame: Initial
Angiographic restenosis
Time frame: 9 months
Target vessel revascularization
Time frame: 1 year
Target lesion revascularization
Time frame: 2 year
Target vessel revascularization
Time frame: 2 year
Incidences of acute, sub acute, and late stent thrombosis
Time frame: 2 year
Incidence of MACCE
defined as cardiac death, nonfatal acute myocardial infarction and cerebrovascular events
Time frame: 2 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Japanese Red Cross Nagoya Daiichi Hospital
Nagoya, Aichi-ken, Japan
Toyohashi Heart Center
Toyohashi, Aichi-ken, Japan
Higashi Cardiovascular clinic
Toyohashi, Aichi-ken, Japan
Hiraka General Hospital
Yokote, Akita, Japan
Saiseikai Fukuoka General Hospital
Fukuoka, Fukuoka, Japan
Kokura memorial hospital
Kitakyushu, Fukuoka, Japan
Hoshi General Hospital
Kōriyama, Fukushima, Japan
Gunma Prefectural Cardiovascular Center
Maebashi, Gunma, Japan
Abashiri Kosei General Hospital
Abashiri, Hokkaido, Japan
Engaru-Kosei General Hospital
Engaru, Hokkaido, Japan
...and 21 more locations